drugset / Trial / NCT00818129

Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese

NCT00818129 ↗

Phase 1 Completed 62 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to investigate the safety and tolerability of single and multiple oral doses of AZD7295 in healthy male Japanese subjects. This will be done by comparing the effect of AZD7295 to placebo. The study will aslo investigate the absorption, distribution and disappearance of AZD7295 in the body.

Timeline

Start
2008-12
Primary completion
—
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7295 Small molecule 90 mg Oral

Indications

No indication recorded.